<?xml version="1.0" encoding="UTF-8"?>
<p>As a large percentage of HEV infections do not present with symptoms, the disease often goes undiagnosed. In individuals presenting with hepatitis, symptoms are indistinguishable from those of hepatitis A. Standard diagnostic tests for hepatitis E include the detection of HEV-specific antibodies, including both anti-HEV IgM and IgG, as well as amplification of the viral genome using conventional PCR or real-time reverse transcription PCR [
 <xref rid="B176-pathogens-09-00856" ref-type="bibr">176</xref>]. During the last decades, WHO international standard materials have been developed to assist standardization of NAT and anti-HEV IgG detection assays [
 <xref rid="B177-pathogens-09-00856" ref-type="bibr">177</xref>,
 <xref rid="B178-pathogens-09-00856" ref-type="bibr">178</xref>]. Awareness of the need for HEV testing has been increasing over the last decade, and many countries have begun to implement HEV RNA screening in blood donations [
 <xref rid="B179-pathogens-09-00856" ref-type="bibr">179</xref>].
</p>
